A medication containing cannabidiol, which is derived from marijuana plants, recently received preliminary approval from the Federal Drug Administration. The approval for the product, Epidiolex, was given for the treatment of Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and … Read More
The post In an FDA first, cannabinoid drug wins preliminary approval appeared first on Dagga Magazine.